Scutellarein from Erigeron breviscapus Inhibits Apoptosis-Mediated Epithelial Barrier Disruption and Alleviates Cigarette Smoke-Induced Lung Injury
<b>Background/Objectives</b>: Cigarette smoke (CS) drives pathogenesis across the spectrum of chronic respiratory disorders, exerting its detrimental effects primarily through oxidative stress and programmed cell death. Scutellarein (Scu), a botanical-origin flavonoid enriched in respiratory therapeutics-oriented Chinese medicinal herbs, demonstrates established anti-inflammatory applications. This study systematically evaluated the protective roles of Scu against CS-induced lung injury and explored the underlying mechanisms. <b>Methods</b>: Subacute CS-exposed mice were used to evaluate the therapeutic effects of Scu on lung injury. Immunofluorescence and quantitative PCR were used to examine the expression levels of junctional proteins and proinflammatory mediators. Apoptotic cell death was quantified using Annexin V-FITC/7-AAD staining. Transepithelial electrical resistance and dextran permeability assay were used to access the barrier integrity in alveolar epithelial MLE-12 cells. Western blotting was used to detect the changes in the signal pathway. <b>Results</b>: In CS-exposed mice, Scu administration dose-dependently reduced histopathological scores, pulmonary edema, changes in the alveolar structure, and inflammatory cell infiltration. In MLE-12 cells, Scu significantly suppressed cigarette smoke condensate (CSC)-induced inflammatory mediators, oxidative stress, caspase-3 activation, and apoptosis and preserved CSC-suppressed tight junction protein expression and barrier disruption. Scu also rescued CSC-altered expression levels of <i>Hrk</i>, <i>Ecscr</i>, and <i>Myo5b</i> and mitigated the CSC-suppressed PI3K/AKT/mTOR pathway. <b>Conclusions</b>: Scu alleviates CS-induced subacute lung injury through its antioxidant, anti-apoptotic effects to maintain epithelial barrier integrity likely via the mitigation of the CSC-suppressed PI3K/AKT/mTOR pathway.
Authors
- Fang Zhao (ORCID: https://orcid.org/0000-0002-2746-9242)
- Yujing Wang (ORCID: https://orcid.org/0000-0002-2218-7908)
- Haimei Fu (ORCID: https://orcid.org/0000-0002-0277-4603)
- Zhe Cao (ORCID: https://orcid.org/0000-0002-9379-2013)
- Huaduan Liang
- Kerui Ren (ORCID: https://orcid.org/0009-0003-8010-5733)
- Mengmeng Song
- Xu Qin
- Chuchu Xi
Institutions
- China Pharmaceutical University (CN)
Publication Details
- Journal
- Pharmaceuticals
- Published
- 2026-01-08
- DOI
- https://doi.org/10.3390/ph19010113
- Primary Topic
- Flavonoids in Medical Research
- Type
- article
- Field-Weighted Citation Impact
- 0.00